Search Results 721-730 of 13937 for Assay
He later joined the Utah Department of Health Newborn Screening Program, where he developed mass spectrometry–based assay for newborn screening of lysosomal ...
We are in the process of developing a serum steroid assay aimed to discern false-positives from true clinically significant abnormalities in steroid production ...
Omics assays, such as genomics, metabolomics and exposomics. Imaging and physiological measures, such as electroencephalograms. Wearables, such as ...
The purpose of this study is to collect patient samples to Ortho Clinical Diagnostics for evaluation of an in-development VITROS Intact PTH II assay and the ...
... assay obtained at baseline. A Study to Evaluate Aortic Dilatation in Patients with Conotruncal Abnormalities Rochester, MN. The purpose of this study is to ...
Developing assays for quantitative analysis of drugs and metabolites in biological fluids. ... Targeted assay development for absolute quantitation of proteins.
Peripheral blood MRD will be measured by the clonoSEQ® assay, with the threshold for MRD negativity set at a sensitivity level of 1 x 10-5 (uMRD5).
... assays using patient peripheral blood immune cells or serum. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer. Rochester ...
HER2 (ERBB2) amplification by CLIA-certified Next Generation Sequencing (NGS) sequencing assay. RAS (KRAS and NRAS) wild-type in primary or metastatic tumor ...
His lab aims to identify novel genetic and chemical modifiers through functional screening in cell-based and biochemical assays, and disease markers using multi ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.